Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
This study is currently recruiting participants.
Verified April 2013 by Van Andel Research Institute
Van Andel Research Institute
Archer Biosciences, Inc.
Information provided by (Responsible Party):
Giselle Sholler, Van Andel Research Institute
First received: November 28, 2011
Last updated: April 5, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||November 2018|
|Estimated Primary Completion Date:||November 2014 (Final data collection date for primary outcome measure)|